Related Experiment Video
Updated: Jan 10, 2026

09:05
In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
Published on: August 20, 2016
8.3K
Exploring corneal endothelial cell dynamics: structure, functions and therapeutic approaches.
Divya N Pai1, Srinivas P Sangly2, Ashwija Shetty3
1Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Department of Anatomy, Mangalore, India.
Molecular Biology Reports
|November 28, 2025
Summary
Corneal endothelial dysfunction impairs vision by disrupting corneal clarity. While surgery is the main treatment, gene therapy and stem cells offer future hope for treating these vision-impairing conditions.
Area of Science:
- Ophthalmology
- Cell Biology
- Regenerative Medicine
Background:
- The corneal endothelium maintains corneal transparency through barrier and pump functions.
- Endothelial dysfunction leads to vision impairment due to loss of corneal clarity.
- The corneal endothelium is critical for regulating corneal hydration and visual acuity.
Purpose of the Study:
- To review the treatment of corneal endothelial pathophysiology.
- To discuss current and emerging therapies for endothelial corneal dystrophies.
- To highlight the importance of surgical interventions and future research directions.
Main Methods:
- This is a review article, synthesizing existing research on corneal endothelial pathophysiology and its treatments.
- It examines the cellular mechanisms underlying corneal clarity and the consequences of their disruption.
- The review analyzes current surgical, pharmacological, and investigational therapeutic approaches.
Main Results:
- Corneal endothelial cell (CEC) loss results in corneal edema, pain, and blurred vision.
- Surgical interventions are the primary treatment for endothelial corneal dystrophies.
- The corneal endothelium does not regenerate in humans, necessitating therapeutic strategies.
Conclusions:
- Surgical approaches are the cornerstone for treating endothelial corneal dystrophies.
- Pharmacological treatments and emerging therapies are crucial adjuncts.
- Future advancements in gene therapy, stem cells, and tissue engineering hold promise for transforming patient management.

